High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients
Author(s) -
Rainer Vormittag,
Ralph Simanek,
Cihan Ay,
Daniela Dunkler,
Peter Quehenberger,
Christine Marosi,
Christoph Zielinski,
Ingrid Pabinger
Publication year - 2009
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.109.190827
Subject(s) - medicine , cancer , risk factor , thrombosis , venous thrombosis , prospective cohort study , gastroenterology , venous thromboembolism , percentile , statistics , mathematics
Patients with cancer are at an increased risk for venous thromboembolism (VTE). Clotting factor VIII activity (FVIII) has been established as risk factor of primary and recurrent VTE. We investigated FVIII as predictive parameter of VTE in cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom